BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dagan Lonsdale//NONSGML Clinical pharmacology year 2 Pharmacokinetics 2 (PHA503) calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:e503630b-3991-46dd-a8a0-b1b3dd542bd5
DTSTAMP:20251002T210920Z
DTSTART:20251002T140000Z
DTEND:20251002T150000Z
SUMMARY:PK 3.1 Introduction to the pharmacokinetics module in year 2 and pharmacokinetic Parameter Estimations preparation session
DESCRIPTION:Module - PHA503, Person delivering - Dagan and team
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:e22b17b5-3ebb-45df-b71d-a9a45672ab6c
DTSTAMP:20251002T210920Z
DTSTART:20251007T090000Z
DTEND:20251007T100000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:b7e5eb81-a83b-4d37-a0d9-7c1dd21e8a51
DTSTAMP:20251002T210920Z
DTSTART:20251007T100000Z
DTEND:20251007T110000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:c4142318-2967-448f-9148-8d5525a16448
DTSTAMP:20251002T210920Z
DTSTART:20251007T110000Z
DTEND:20251007T120000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:dbe6884b-3c04-42fe-8f54-ffc625a43e4b
DTSTAMP:20251002T210920Z
DTSTART:20251016T090000Z
DTEND:20251016T100000Z
SUMMARY:PK 3.4  Blood Brain Barrier
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:Self paced
END:VEVENT
BEGIN:VEVENT
UID:deb8ea43-1e99-4b3b-9dae-de389b3aafcc
DTSTAMP:20251002T210920Z
DTSTART:20251017T140000Z
DTEND:20251017T150000Z
SUMMARY:PK 3.3 Pre-clinical PK and animal to human predictions
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:f333a48f-447d-4c23-89c5-86a400b6577f
DTSTAMP:20251002T210920Z
DTSTART:20251027T100000Z
DTEND:20251027T110000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:87c1766e-2c65-4c21-af05-2902e57366b4
DTSTAMP:20251002T210920Z
DTSTART:20251027T110000Z
DTEND:20251027T120000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:d54c21e6-d860-48f2-aae7-751646f386ba
DTSTAMP:20251002T210920Z
DTSTART:20251027T120000Z
DTEND:20251027T130000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:8313c841-4389-490f-8787-81b28a7a454b
DTSTAMP:20251002T210920Z
DTSTART:20251030T120000Z
DTEND:20251030T130000Z
SUMMARY:PK 3.6 Introduction to topics for Thursday PM  Joint Drug devt and PK
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:dc8daaf4-61ac-4b6b-93ba-21a0256922be
DTSTAMP:20251002T210920Z
DTSTART:20251030T140000Z
DTEND:20251030T150000Z
SUMMARY:PK 3.7 study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq/Toqa, external lecturer David Carlisle
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:150fdc81-412a-4a79-9525-ef040b2bfe39
DTSTAMP:20251002T210920Z
DTSTART:20251030T150000Z
DTEND:20251030T160000Z
SUMMARY:PK 3.7 study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq/Toqa, external lecturer David Carlisle
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:38891fb1-0777-4771-899a-29cc1238e67b
DTSTAMP:20251002T210920Z
DTSTART:20251113T100000Z
DTEND:20251113T110000Z
SUMMARY:PK and drug development assignment drop in session
DESCRIPTION:Module - PHA503, Person delivering - Dagan, Ateeq
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:f59bddeb-3d9a-4772-aafa-5f13ef083993
DTSTAMP:20251002T210920Z
DTSTART:20251113T110000Z
DTEND:20251113T120000Z
SUMMARY:PK 3.8 Pharmacogenomics
DESCRIPTION:Module - PHA503, Person delivering - Reya
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:57ae61a9-e1f3-4b24-bb76-08a1a730261b
DTSTAMP:20251002T210920Z
DTSTART:20251113T120000Z
DTEND:20251113T130000Z
SUMMARY:PK 3.9 Bioequivalence 2
DESCRIPTION:Module - PHA503, Person delivering - Toqa
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:86d4a568-93a9-4aee-bd1c-baaf211eca68
DTSTAMP:20251002T210920Z
DTSTART:20251205T140000Z
DTEND:20251205T150000Z
SUMMARY:PK 3.10 Pharmacokinetics and PD in aging and pregnancy
DESCRIPTION:Module - PHA503, Person delivering - ?Cleodie
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:0fb654f7-569c-4ddb-be78-b9d8f4c0afe9
DTSTAMP:20251002T210920Z
DTSTART:20251208T100000Z
DTEND:20251208T110000Z
SUMMARY:PK 3.11 Pharmacokinetic Variability and Assignment Debrief
DESCRIPTION:Module - PHA503, Person delivering - Dagan, Toqa, Ateeq, Dan
LOCATION:Lecture theatre A
END:VEVENT
BEGIN:VEVENT
UID:c4d4c69f-c1d0-41f5-ad52-9540acd3834a
DTSTAMP:20251002T210920Z
DTSTART:20260108T140000Z
DTEND:20260108T150000Z
SUMMARY:PK 3.12  Introduction to PK modelling
DESCRIPTION:Module - PHA503, Person delivering - Prof. Joe Standing
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:ffff6875-c3cf-4e20-acaa-a8219a73fb83
DTSTAMP:20251002T210920Z
DTSTART:20260108T150000Z
DTEND:20260108T160000Z
SUMMARY:PK 3.13  Introduction to Compartmental analysis
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:TBC
END:VEVENT
END:VCALENDAR
